Liao Carrie
- SEC CIK
- 0001899817
No open-market purchases or sales filed in the past year.
Current role at each company
- DFTX Definium Therapeutics, Inc.Chief Accounting Officeras of Mar 26, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Liao Carrie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 (view filing) | Mar 25 | 1 day | Liao CarrieChief Accounting Officer | SSale | −2.35K | $6.74 | −$15.8K | −1.6%144.9K after | 10b5-1 |
| Dec 27, 2024 (view filing) | Dec 26 | 1 day | Liao CarrieChief Accounting Officer | SSale | −2.27K | $7.43 | −$16.9K | −2.3%97.3K after | 10b5-1 |
| Sep 25, 2024 (view filing) | Sep 25 | Same day | Liao CarrieChief Accounting Officer | SSale | −2.35K | $5.98 | −$14.1K | −2.3%99.5K after | 10b5-1 |